Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights
- PMID: 37138857
- PMCID: PMC10149834
- DOI: 10.3389/froh.2023.942604
Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights
Abstract
Pleomorphic adenoma (PA) is the most common salivary gland tumor, accounting for 50%-60% of these neoplasms. If untreated, 6.2% of PA may undergo malignant transformation to carcinoma ex-pleomorphic adenoma (CXPA). CXPA is a rare and aggressive malignant tumor, whose prevalence represents approximately 3%-6% of all salivary gland tumors. Although the pathogenesis of the PA-CXPA transition remains unclear, CXPA development requires the participation of cellular components and the tumor microenvironment for its progression. The extracellular matrix (ECM) comprises a heterogeneous and versatile network of macromolecules synthesized and secreted by embryonic cells. In the PA-CXPA sequence, ECM is formed by a variety of components including collagen, elastin, fibronectin, laminins, glycosaminoglycans, proteoglycans, and other glycoproteins, mainly secreted by epithelial cells, myoepithelial cells, cancer-associated fibroblasts, immune cells, and endothelial cells. Like in other tumors including breast cancer, ECM changes play an important role in the PA-CXPA sequence. This review summarizes what is currently known about the role of ECM during CXPA development.
Keywords: carcinogenesis; carcinoma ex pleomorphic adenoma (CXPA); extracellular matrix (ECM); pleomorphic adenoma (PA); review.
© 2023 Scarini, de Lima-Souza, Lavareze, Ribeiro de Assis, Damas, Altemani, Egal, dos Santos, Bello and Mariano.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Pleomorphic adenoma and carcinoma ex-pleomorphic adenoma tumorigenesis: A proteomic analysis.Oral Dis. 2025 Mar;31(3):865-878. doi: 10.1111/odi.15109. Epub 2024 Aug 18. Oral Dis. 2025. PMID: 39155517 Free PMC article.
-
Extracellular matrix remodelling and stiffening contributes to tumorigenesis of salivary carcinoma ex pleomorphic adenoma--A study based on patient-derived organoids.Cell Biosci. 2023 Jul 1;13(1):122. doi: 10.1186/s13578-023-01071-x. Cell Biosci. 2023. PMID: 37393249 Free PMC article.
-
Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.Hum Pathol. 2016 Nov;57:152-159. doi: 10.1016/j.humpath.2016.07.011. Epub 2016 Jul 26. Hum Pathol. 2016. PMID: 27473265
-
Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.Head Neck Pathol. 2018 Mar;12(1):82-88. doi: 10.1007/s12105-017-0829-7. Epub 2017 Jun 6. Head Neck Pathol. 2018. PMID: 28589437 Free PMC article. Review.
-
Insights into the molecular alterations of PLAG1 and HMGA2 associated with malignant phenotype acquisition in pleomorphic adenoma.Crit Rev Oncol Hematol. 2024 Dec;204:104494. doi: 10.1016/j.critrevonc.2024.104494. Epub 2024 Sep 13. Crit Rev Oncol Hematol. 2024. PMID: 39278426 Review.
Cited by
-
A Case of Pleomorphic Adenoma and Ductal Carcinoma In Situ in the Same Mammary Gland.Surg Case Rep. 2025;11(1):24-0100. doi: 10.70352/scrj.cr.24-0100. Epub 2025 Feb 8. Surg Case Rep. 2025. PMID: 40008370 Free PMC article.
-
Pleomorphic adenoma and carcinoma ex-pleomorphic adenoma tumorigenesis: A proteomic analysis.Oral Dis. 2025 Mar;31(3):865-878. doi: 10.1111/odi.15109. Epub 2024 Aug 18. Oral Dis. 2025. PMID: 39155517 Free PMC article.
-
How predominant cell and stroma types harmonize to predict head and neck adenoid cystic carcinoma outcomes?Med J Armed Forces India. 2024 Jul-Aug;80(4):404-411. doi: 10.1016/j.mjafi.2024.05.012. Epub 2024 Jun 21. Med J Armed Forces India. 2024. PMID: 39071760 Free PMC article. Review.
-
High-throughput glycosaminoglycan extraction and UHPLC-MS/MS quantification in human biofluids.Nat Protoc. 2025 Apr;20(4):843-860. doi: 10.1038/s41596-024-01078-9. Epub 2024 Nov 14. Nat Protoc. 2025. PMID: 39543382 Review.
-
Pattern of SOX9 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma, and matrix-producing metaplastic carcinoma of the breast lends support to common biology.Virchows Arch. 2025 Jun 30. doi: 10.1007/s00428-025-04161-y. Online ahead of print. Virchows Arch. 2025. PMID: 40583066
References
-
- Bell D, Bullerdiek J, Gnepp DR, Schwartz MR, Stenman G, Triantafyllou A. Pleomorphic adenoma. In: El-Naggar A, Chan JKC, Grandis JR, Takata T, Slootweg P, editors. World health organization classification of tumours. Lyon: IARC Press; (2017). p. 185–6.
-
- Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. (1993) 28(Pt 1):279–328. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8380049. - PubMed
Publication types
LinkOut - more resources
Full Text Sources